Making Health Care Work Updates

News Release | U.S. PIRG Education Fund | Health Care

U.S. PIRG Education Fund Announces “Health Insurance 101” Campus Education Campaign

U.S. PIRG Education Fund celebrated the kick-off of its new health care outreach and education effort focusing on young Americans. The outreach effort comes as the Affordable Care Act’s “health insurance marketplaces” prepare to open in states across the country.

News Release | U.S. PIRG | Health Care

U.S. PIRG Testifies on “Pay for Delay” Before Senate Subcommittee

Today, Mike Russo, U.S. PIRG's Federal Program Director, testified at a hearing on “Pay-for-Delay Deals: Limiting Competition and Costing Consumers” held by the Senate Judiciary Committee, Subcommittee on Antitrust, Competition and Consumer Rights.

Report | U.S. PIRG | Health Care

Top Twenty Pay-For-Delay Drugs

Our research revealed 20 major drugs that were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

News Release | U.S. PIRG | Health Care

Twenty Top Generic Drugs Delayed By Industry Payoffs

Americans with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs, according to a report released today by Community Catalyst and U.S. PIRG.

News Release | U.S. PIRG | Health Care

Big Pharma's Pay-for-Delay Deals Take a Hit

Big Pharma's controversial "pay-for-delay" agreements took a hit today. In FTC v. Actavis, the U.S. Supreme Court ruled that the Federal Trade Commission (FTC) case against the payoff keeping generic AndroGel from the market can move ahead in the lower courts. The court chose not to declare all such payoffs unlawful, however, spurring consumer advocates to call on Congress to finish the job. 

Report | U.S. PIRG | Public Health, Health Care

Prescription for Danger

Compounding pharmacies are increasingly behaving like pharmaceutical companies by producing drugs in bulk, despite the fact that they are not inspected or regulated like the pharmaceutical industry. Due to this lack of oversight, many compounding pharmacies have not adhered to safe manufacturing practices, and shown little regard for consumer safety. According to an analysis of warning letters sent to other compounding pharmacies by the FDA from 2002 to 2012, there is a long history of violations that have in many cases led to unnecessary illness, injury, and even death.

News Release | U.S. PIRG | Public Health, Health Care

New Report Documents a Decade of Safety Violations by Compounding Pharmacies

The contaminated drug that caused last fall's fungal meningitis outbreak and killed 55 people is just the tip of the iceberg of an industry-wide problem, according to a new U.S. PIRG report. The meningitis outbreak was simply the latest and deadliest in a long line of errors and risky practices by compounding pharmacies.

Senate panel approves tighter oversight of compounding pharmacies but bill is under fire

Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks.

What's Next on Health Care Costs?

By

Now that the election is over, talk has turned to the need to work together and get results for America. It’s a tall order, and on the polarized issue of health care, it may seem like an impossible task. But here's why I'm optimistic that we can in fact make progress.

Here’s that Rx refill you didn’t order

By

Is your pharmacy refilling your prescription without your knowledge or approval, and billing your insurance company for the cost? If so, it’s the latest example of waste we shouldn't tolerate in our health care system.

Pages

Priority Action

The overuse of antibiotics on factory farms is threatening the effectiveness of lifesaving antibiotics. Call on the Obama administration to put an end to the worst practices.

Support Us

Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.